tiprankstipranks
Trending News
More News >
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE

Ultragenyx Pharmaceutical (RARE) Similar Stocks

Compare
800 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ultragenyx Pharmaceutical
$38.09
$3.58B
-13.90%
15 Buy
1 Hold
0 Sell
Strong Buy
Amicus
$7.35
$2.21B
-28.50%
6 Buy
2 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$63.30
$12.14B
28.78
-21.76%
16 Buy
5 Hold
0 Sell
Strong Buy
Vertex Pharmaceuticals
$493.84
$126.96B
24.24%
16 Buy
10 Hold
1 Sell
Moderate Buy
Sarepta Therapeutics
$60.44
$5.86B
25.36
-53.06%
18 Buy
4 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$38.27
$3.30B
-29.01%
12 Buy
6 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RARE
Ultragenyx Pharmaceutical
38.09
-5.93
-13.47%
FOLD
Amicus
7.35
-2.90
-28.29%
BMRN
BioMarin Pharmaceutical
63.30
-18.83
-22.93%
VRTX
Vertex Pharmaceuticals
493.84
97.64
24.64%
SRPT
Sarepta Therapeutics
60.44
-68.36
-53.07%
CRSP
Crispr Therapeutics AG
38.27
-16.56
-30.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis